Adaptive Biotechnologies ADPT Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's software and technology licenses, net?
- Adaptive Biotechnologies (ADPT) reported software and technology licenses, net of $1.24M in Q1 2026.
- How has Adaptive Biotechnologies's software and technology licenses, net changed year-over-year?
- Adaptive Biotechnologies's software and technology licenses, net decreased by 34.4% year-over-year, from $1.89M to $1.24M.
- What is the long-term trend for Adaptive Biotechnologies's software and technology licenses, net?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's software and technology licenses, net has grown at a 15.1% compound annual growth rate (CAGR), from $598K to $1.21M.